Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9234177rdf:typepubmed:Citationlld:pubmed
pubmed-article:9234177lifeskim:mentionsumls-concept:C1527169lld:lifeskim
pubmed-article:9234177lifeskim:mentionsumls-concept:C0013018lld:lifeskim
pubmed-article:9234177lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:9234177lifeskim:mentionsumls-concept:C0524864lld:lifeskim
pubmed-article:9234177pubmed:issue3lld:pubmed
pubmed-article:9234177pubmed:dateCreated1997-10-16lld:pubmed
pubmed-article:9234177pubmed:abstractTextWe studied peripheral blood and apheresis samples from 39 consecutive normal donors who were parents or siblings of patients who received matched or mismatched bone marrow transplants using a combination of rhG-CSF-mobilized peripheral blood stem cells (PBSCs) and bone marrow (BM). BM was harvested from donors 1-7 days before starting rhG-CSF treatment: 12 micrograms/kg/day rhG-CSF was administered by continuous s.c. infusion for 4-7 days. Peripheral blood progenitor cells were harvested by leukapheresis using an automated continuous-flow blood cell separator, beginning on day 4 of rhG/CSF, for 1-4 consecutive days. Peak peripheral blood CD34+ cell and CFU-GM levels were reached simultaneously on day 5 or 6 of rhG-CSF administration. Median peak levels were 1.65% for CD34+ cells (range 0.34%-4.7%) and 142 CFU-GM/10(5) plated cells (range 16-700). The greatest numbers of CD34+ cells and CFU-GM, expressed per liter of blood volume processed, were harvested during the second and third leukapheresis: CD34+ cells 37.77 +/- 25.48 x 10(6) and CFU-GM 3.32 +/- 2.51 x 10(6) during the second leukapheresis, and CD34+ cells 37.01 +/- 16.33 x 10(6) and CFU-GM 3.82 +/- 4.36 x 10(6) during the third. The number of CD34+ cells and CFU-GM did not correlate with the sex, age, or body weight of the donors. This study indicates that this protocol for administration of rhG-CSF mobilizes large numbers of hematopoietic progenitor cells into the peripheral blood and that bone marrow harvesting before G-CSF administration does not impair stem cell mobilization.lld:pubmed
pubmed-article:9234177pubmed:languageenglld:pubmed
pubmed-article:9234177pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234177pubmed:citationSubsetIMlld:pubmed
pubmed-article:9234177pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234177pubmed:statusMEDLINElld:pubmed
pubmed-article:9234177pubmed:monthJunlld:pubmed
pubmed-article:9234177pubmed:issn1061-6128lld:pubmed
pubmed-article:9234177pubmed:authorpubmed-author:MartelliM FMFlld:pubmed
pubmed-article:9234177pubmed:authorpubmed-author:AversaFFlld:pubmed
pubmed-article:9234177pubmed:authorpubmed-author:RossettiMMlld:pubmed
pubmed-article:9234177pubmed:authorpubmed-author:CaputiVVlld:pubmed
pubmed-article:9234177pubmed:authorpubmed-author:MartelliM PMPlld:pubmed
pubmed-article:9234177pubmed:authorpubmed-author:TabilioAAlld:pubmed
pubmed-article:9234177pubmed:authorpubmed-author:FalzettiFFlld:pubmed
pubmed-article:9234177pubmed:authorpubmed-author:GiannoniCClld:pubmed
pubmed-article:9234177pubmed:authorpubmed-author:ChionneFFlld:pubmed
pubmed-article:9234177pubmed:authorpubmed-author:GambelungheCClld:pubmed
pubmed-article:9234177pubmed:issnTypePrintlld:pubmed
pubmed-article:9234177pubmed:volume6lld:pubmed
pubmed-article:9234177pubmed:ownerNLMlld:pubmed
pubmed-article:9234177pubmed:authorsCompleteYlld:pubmed
pubmed-article:9234177pubmed:pagination227-34lld:pubmed
pubmed-article:9234177pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:meshHeadingpubmed-meshheading:9234177-...lld:pubmed
pubmed-article:9234177pubmed:year1997lld:pubmed
pubmed-article:9234177pubmed:articleTitleStem cell mobilization in normal donors.lld:pubmed
pubmed-article:9234177pubmed:affiliationDepartment of Clinical Medicine, Pathology, and Pharmacology, Haematology, University of Perugia, Italy.lld:pubmed
pubmed-article:9234177pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9234177pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9234177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9234177lld:pubmed